<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: PCYC News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=pcyc</link><description>Latest Financial News for Pharmacyclics, Inc.</description><language>en-us</language><lastBuildDate>Tue, 15 Dec 2009 00:00:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Form 10 K for Pharmacyclics (WILink)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://yahoo.ar.wilink.com?ticker=PCYC&amp;mkt_code=YAH-HDLN-A&amp;1260940873</link><description></description><guid isPermaLink="false">yahoo_finance/1684273048</guid><pubDate>Tue, 15 Dec 2009 00:00:00 Etc/GMT</pubDate></item><item><title>PHARMACYCLICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091208/pcyc8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/134152091</guid><pubDate>Tue, 8 Dec 2009 11:00:55 Etc/GMT</pubDate></item><item><title>Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091207/sf21700.html?.v=1</link><description>Pharmacyclics, Inc. today announced interim data from a Phase I study of their novel orally administered Bruton&apos;s tyrosine kinase inhibitor PCI-32765 in patients with relapsed or refractory B-cell non-Hodgkin&apos;s lymphoma or chronic lymphocytic leukemia .</description><guid isPermaLink="false">yahoo_finance/2966725747</guid><pubDate>Tue, 8 Dec 2009 00:00:00 Etc/GMT</pubDate></item><item><title>PHARMACYCLICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091207/pcyc8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2073100178</guid><pubDate>Mon, 7 Dec 2009 11:00:58 Etc/GMT</pubDate></item><item><title>Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091206/sf21701.html?.v=1</link><description>Pharmacyclics, Inc. today announced interim results from a Phase I/II study showing safety and clinical activity in patients with relapsed / recurrent non-Hodgkin&apos;s Lymphoma treated with its HDAC inhibitor PCI-24781 as a single agent.</description><guid isPermaLink="false">yahoo_finance/4033453043</guid><pubDate>Mon, 7 Dec 2009 00:00:00 Etc/GMT</pubDate></item><item><title>Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 &amp; 7 (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091203/ny20927.html?.v=1</link><description>Pharmacyclics, Inc. , a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune mediated diseases and cancer, today announced that it will host a webcast and conference call on, Tuesday, December 8, 2009 at 11:00am Eastern Time to discuss clinical data regarding its HDAC Program and its BTK Program that will be presented at the American Society of Hematology meeting.</description><guid isPermaLink="false">yahoo_finance/3991202527</guid><pubDate>Thu, 3 Dec 2009 21:30:00 Etc/GMT</pubDate></item><item><title>Still Believe in Antigenics (at Seeking Alpha)</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=1269ahjb7/*http%3A//seekingalpha.com/article/175150-still-believe-in-antigenics?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/1578757303</guid><pubDate>Tue, 24 Nov 2009 21:19:42 Etc/GMT</pubDate></item><item><title>PHARMACYCLICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091112/pcyc8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1266414245</guid><pubDate>Thu, 12 Nov 2009 21:36:14 Etc/GMT</pubDate></item><item><title>Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091112/ny10566.html?.v=1</link><description>Pharmacyclics, Inc. today announced that posters related to PCI-24781 and PCI-32765 have been selected for presentation at the 51st Annual Meeting of the American Society of Hematology , December 5-8, 2009 in New Orleans, LA.</description><guid isPermaLink="false">yahoo_finance/2269569112</guid><pubDate>Thu, 12 Nov 2009 21:11:00 Etc/GMT</pubDate></item><item><title>Pharmacyclics to Present at Merriman Curhan Ford&apos;s Investor Summit 2009 (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091109/ny07497.html?.v=1</link><description>Pharmacyclics, Inc. , a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune mediated diseases and cancer, today announced that Dr.</description><guid isPermaLink="false">yahoo_finance/92247405</guid><pubDate>Mon, 9 Nov 2009 14:00:00 Etc/GMT</pubDate></item><item><title>PHARMACYCLICS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091103/pcyc10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/3604703220</guid><pubDate>Tue, 3 Nov 2009 21:30:27 Etc/GMT</pubDate></item><item><title>CEO Interview: Provectus Pharmaceuticals, Inc. - Peter R. Culpepper (Wall Street Transcript)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/twst/091102/ang611.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/1658094216</guid><pubDate>Mon, 2 Nov 2009 20:09:00 Etc/GMT</pubDate></item><item><title>PHARMACYCLICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091102/pcyc8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/862031464</guid><pubDate>Mon, 2 Nov 2009 11:01:06 Etc/GMT</pubDate></item><item><title>Pharmacyclics Reports First Quarter Fiscal 2010 Financial Results (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091029/ny02073.html?.v=1</link><description>Pharmacyclics, Inc. today reported financial results for its first fiscal quarter ended September 30, 2009. The net loss for the first quarter of fiscal 2010 was $4.8 million, or $0.12 per share, compared to a net loss of $6.5 million, or $0.25 per share, in the first quarter of fiscal 2009.</description><guid isPermaLink="false">yahoo_finance/2224323443</guid><pubDate>Thu, 29 Oct 2009 20:57:00 Etc/GMT</pubDate></item><item><title>PHARMACYCLICS INC Financials (EDGAR Online Financials)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=pcyc</link><description></description><guid isPermaLink="false">yahoo_finance/2665510879</guid><pubDate>Sat, 26 Sep 2009 13:04:17 Etc/GMT</pubDate></item><item><title>PHARMACYCLICS INC Files SEC form 10-K, Annual Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090922/pcyc10-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1868937414</guid><pubDate>Tue, 22 Sep 2009 19:58:15 Etc/GMT</pubDate></item><item><title>PHARMACYCLICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090917/pcyc8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1619080515</guid><pubDate>Thu, 17 Sep 2009 20:16:27 Etc/GMT</pubDate></item><item><title>PHARMACYCLICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090806/pcyc8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3142468754</guid><pubDate>Thu, 6 Aug 2009 17:18:23 Etc/GMT</pubDate></item><item><title>PHARMACYCLICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090724/pcyc8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2210418183</guid><pubDate>Fri, 24 Jul 2009 21:31:24 Etc/GMT</pubDate></item><item><title>PHARMACYCLICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090717/pcyc8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/348354521</guid><pubDate>Fri, 17 Jul 2009 21:08:11 Etc/GMT</pubDate></item></channel></rss><!-- c4.finance.sp2.yahoo.com compressed/chunked Sun Dec 27 23:34:18 PST 2009 -->
